FCAP Q1 2026 Earnings Solid EPS of 130 Drives Modest Stock Gain Praxis Precision Medicines Inc PRAX Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue CTO Q1 2026 Earnings Massive EPS Surprise of 374 as FFO Exceeds Expectations Intapp Q1 2026 Earnings Modest EPS Beat Highlights Operational Discipline Amidst Cloud Transition BRFH Q1 2026 Earnings Surpasses EPS Estimates with Narrower Loss Genpact G Q1 2026 Earnings EPS Beat Drives Investor Focus on Margin Strength